Conscious Sedation Study

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

April 1, 2026

Conditions
Atrial Fibrillation
Interventions
DEVICE

CLAAS® System

The CLAAS® System delivers a plug to the ostia of the Left Atrial Appendage (LAA) and is designed to occlude the appendage to eliminate blood flow. It is designed to conform to the geometry of the LAA. The implant is designed to permanently seal off the LAA from the LA with an endothelial layer that forms across the LA face of the implant. The implant is available in two different sizes; Regular (27mm) and Large (35mm) to accommodate patient anatomy. Angiography and/or echocardiography may be used to determine the LAA ostium diameter to properly select the Implant size. The implant has an inner, cylindrical, Nitinol endoskeleton that provides the mechanical base structure. The Nitinol endoskeleton contains 10 face struts and 20 anchors (Regular) and 12 struts and 24 anchors (Large) facing proximally to engage the tissue to resist movement. The endoskeleton also provides the conformable structure to enable the foam cylinder to compress against the LAA tissue to facilitate sealing.

Sponsors
All Listed Sponsors
lead

Conformal Medical, Inc

INDUSTRY